ConductScience.org, home

Paper42495331

Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications.

Belete M and 2 others. ACS Omega, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications. Papers, record 42495331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42495331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications.
PubMed
Journal
ACS Omega
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Belete MMlishttps://orcid.org/0000-0002-3049-6065
2Melaku YYadessahttps://orcid.org/0000-0003-2599-0517
3Mulugeta EEndalehttps://orcid.org/0000-0002-2869-0934

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138856835Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review.Mol Divers2025https://conductscience.org/library/papers/38856835PubMed
235755264Novel Pyrimidine Derivatives Bearing a 1,3,4-Thiadiazole Skeleton: Design, Synthesis, and Antifungal Activity.Front Chem2022https://conductscience.org/library/papers/35755264PubMed
319670193The three-component biginelli reaction: a combined experimental and theoretical mechanistic investigation.Chemistry2009https://conductscience.org/library/papers/19670193PubMed
439834253Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities.Arch Pharm (Weinheim)2025https://conductscience.org/library/papers/39834253PubMed
525383216Significance and biological importance of pyrimidine in the microbial world.Int J Med Chem2014https://conductscience.org/library/papers/25383216PubMed
631517529Recent advances of thiazole hybrids in biological applications.Future Med Chem2019https://conductscience.org/library/papers/31517529PubMed
739133616Antioxidant and Antimicrobial Activities of 4H-Chromene Based Indole-Pyrimidine Hybrids: Synthesis and Molecular Docking Studies.Chem Biodivers2024https://conductscience.org/library/papers/39133616PubMed
841602180Thienopyrimidine scaffolds as promising antimicrobial agents: synthesis, biological evaluation, DFT analysis and molecular docking.RSC Adv2026https://conductscience.org/library/papers/41602180PubMed
941815403
Regioselective synthesis, structural investigation and binding behavior of 6-aroyl-7-aryl-5-methyl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidines with BSA using various spectroscopic and in silico methods.
RSC Adv2026https://conductscience.org/library/papers/41815403PubMed
1039691514Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization.ACS Med Chem Lett2024https://conductscience.org/library/papers/39691514PubMed
1138837417Unlocking nitrogen compounds' promise against malaria: A comprehensive review.Arch Pharm (Weinheim)2024https://conductscience.org/library/papers/38837417PubMed
1239456793Pyrimidine Derivatives as Selective COX-2 Inhibitors with Anti-Inflammatory and Antioxidant Properties.Int J Mol Sci2024https://conductscience.org/library/papers/39456793PubMed
1337197676Antioxidant activity of novel nitrogen scaffold with docking investigation and correlation of DFT stimulation.RSC Adv2023https://conductscience.org/library/papers/37197676PubMed
1440504040Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives.ChemMedChem2025https://conductscience.org/library/papers/40504040PubMed
1541531954Radiosynthesis and Preclinical Evaluation of a Novel 11C‑Labeled Pyrazolopyrimidine Derivative for Positron Emission Tomography Imaging of Phosphodiesterase 2A.ACS Med Chem Lett2026https://conductscience.org/library/papers/41531954PubMed
1632797654Recent Development of Pyrimidine-Containing Antimicrobial Agents.ChemMedChem2020https://conductscience.org/library/papers/32797654PubMed
1740656568
De novo drug design and biological evaluation of coumarin-pyrimidine co-drug derivatives as diabetic inhibitors: expanding a multi-algorithm approach with the integration of machine learning in pharmaceutical research.
RSC Adv2025https://conductscience.org/library/papers/40656568PubMed
1841519811Synthesis and antitumor property of triazole-aryloxyacetyl hydrazide hybrids with furo[2,3-d]pyrimidine scaffold.BMC Chem2026https://conductscience.org/library/papers/41519811PubMed
1941900130Nanoparticle-Catalysed Microwave-Driven MCRs for Sustainable Heterocycle Synthesis.Molecules2026https://conductscience.org/library/papers/41900130PubMed
2041381722Synthesis, molecular docking, ADMET studies and biological evaluation of fused pyrazolopyridopyrimidine derivatives as antioxidant and antimicrobial agents.Sci Rep2025https://conductscience.org/library/papers/41381722PubMed

See all 72 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42943798Coumarin-Ferulic Acid Hybrid Mediates HT-29-Selective Growth Inhibition and Proteomic Profiling.Molecules2026https://conductscience.org/library/papers/42943798

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MT-CO24513PubTator's text mininghttps://conductscience.org/library/genes/4513NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42495331

GET https://conductscience.org/api/papers/v1/42495331/references?page=2